Rapport sur les populations clés.
Поэтому уже давно возникала мысль о том,что подробный комментарий по вопросам научных знаний и практическогоопыта, лежащих в основе политики ВОЗ по борьбе ...с туберкулезом, являлся бысущественным элементом технического сотрудничества ВОЗ с ее государствамичленами. Данная книга, написанная в форме вопросов и ответов, являетсяпервым шагом в этом направлении. Я надеюсь, что она станет доступной длявсех специалистов, участвующих в борьбе с туберкулезом, организаторов здравоохранения и администраторов, ответственных за формирование и выполнение национальных программ борьбы с туберкулезом, а также всех медицинскихработников, ежедневно решающих конкретные задачи борьбы с туберкулезомна местах.
more
Annex to Selection and use of Ebola in vitro diagnostic assays
Представлены литературные данные о полиморфизме психических расстройств в периоде перименопаузы у женщин и о теориях возникновения климактерического синдрома. ...огласно современной гипотезе, мелатонин обладает антигонадотропными свойствами. Резкое снижение уровня мелатонина в организме человека в период полового созревания способствует активации гонадотропной функции гипофиза, выработке фолликул стимулирующего гормона и лютеинизирующего гормона, которые оказывают стимулирующее влияние на половые железы. Участие мелатонина в патогенезе климактерического синдрома изучено недостаточно, а исследования, посвященные использованию мелатонина в качестве лечебного средства, противоречивы. Дальнейшее изучение роли мелатонина в возникновении КС позволит понять возможности психофармакотерапии рассматриваемых расстройств.
more
Available in german, arabic, english, greek, croatian, kurdish, italian, polish, portugüse, russian, spanish, turkish, vietnamese
https://www.migration-gesundheit.bund.de/de/gesundheit-und-vorsorge/fraüngesundheit/
Временные рекомендации
19 марта 2020 г.
Настоящий документ предназначен для министров здравоохранения, руководителей органов здравоохранения и других ответствен...ных руководителей. Цель документа – предоставить методические рекомендации по организации оказания помощи пациентам с COVID-19 в условиях высокой нагрузки на систему здравоохранения, а тажке по обеспечению доступа пациентов с COVID-19 к неотложной медицинской помощи без ущерба для решения других задач в области здравоохранения и при обеспечении безопасности медицинского персонала.
more
The International Corrections and Prisons Association is committed to provide you with the most up-to-date information. As we are all experiencing the effects of the Global Pandemic of COVID-19, ICPA reached out to colleagues from across the world, with the idea to collect useful resources that coul...d be implemented in our respective jurisdictions. Please feel free to download the documents
more
Accessed: 22.04.2020
The outbreak and spread of the COVID-19 virus confronts Prison Services daily with new challenges.
Prison Services are dealing with closed environments and this makes it especially difficult to provide for the right care for both, prisoners and staff working in prisons.
Pri...son Services are eager to hear from their colleagues in other European countries, how they are dealing with this situation, what approaches and measures they took to keep the situation as much as possible under control.
On this page we would like to gather and share all regulations/protocols/approaches European Prison Services or related organisations have drafted or taken in order to deal with the Covid-19 virus.
more
This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of contacts, tracing of contacts, screening of contacts, ad...ministration of prophylactic drugs. Managerial aspects to undertake contact screeninig and chemoprophylaxis are also elaborated, including planning , training , supervision and drug management.
more
This e-learning course is designed for front-line managers of institutions hosting or serving people who are medially or socially vulnerable to the impact of COVID-19. It is a non-moderated and self-paced course. You can decide when to start it, interrupt and resume to continue at any time. In total..., the course is designed to take from 1 to 3 hours to complete. The content of this course is available in all 24 EU official working languages.
more
The COVID-19 CARE pathway is a living tool to support health care workers visualize the current clinical and therapeutic recommendations to be considered in the care planning for patients with COVID-19.
The COVID-19 CARE pathway is aligned with the eighth version of the WHO Therapeutics and COVID...-19: living guideline published on the 14 January 2022 and the third version of the WHO COVID-19 Clinical management: living guidance published on the 23 November 2021.
more
Volume 3, Cancer, presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The DCP3 evaluation of cancer will indicate where cancer treatment is ineffective and wasteful, and offer alternative cancer care packa...ges that are cost-effective and suited to low-resource settings. Main messages from the volume include:
-Quality matters in all aspects of cancer treatment and palliation.
-Cancer registries that track incidence, mortality, and survival paired with systems to capture causes of death are important to understanding the national cancer burden and the effect of interventions over time.
-Effective interventions exist at a range of prices. Adopting ‘resource appropriate’ measures which allow the most effective treatment for the greatest number of people will be advantageous to countries.
-Prioritizing resources toward early stage and curable cancers is likely to have the greatest health impact in low income settings.
-Research prioritization is no longer just a global responsibility.
more
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries.
In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response.
As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa.
more